Biased Opioid Ligands: Revolution or Evolution?
Opioid are the most powerful analgesics ever but their use is still limited by deleterious side effects such as tolerance, dependence, and respiratory depression that could eventually lead to a fatal overdose. The opioid crisis, mainly occurring in north America, stimulates research on finding new o...
Main Authors: | Florence Noble, Nicolas Marie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pain Research |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpain.2021.722820/full |
Similar Items
-
Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain – A Review of Current Evidence
by: Tan HS, et al.
Published: (2021-04-01) -
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
by: Singla N, et al.
Published: (2017-10-01) -
Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation
by: Zhennan Zhao, et al.
Published: (2020-07-01) -
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
by: Joaquim Azevedo Neto, et al.
Published: (2020-08-01) -
Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
by: Mengjun Ma, et al.
Published: (2019-01-01)